Company Filing History:
Years Active: 1997
Title: Ralph Hanni: Innovator in Pharmaceutical Chemistry
Introduction
Ralph Hanni is a notable inventor based in Fullinsdorf, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of important compounds used in medicine. His innovative work has led to the development of a specific patent that showcases his expertise and dedication to advancing healthcare solutions.
Latest Patents
Ralph Hanni holds a patent for the "Process for the preparation of dihydroartemisinin hemisuccinate." This process involves the acylation of dihydroartemisinin with 1.0 to 1.3 molar equivalents of succinic anhydride. It is conducted in the presence of 0.5 to 1.5 molar equivalents of tri(C.sub.1 -C.sub.3 -alkyl)amine in a low-boiling, neutral, water-miscible, inert organic solvent or solvent mixture. The subsequent isolation of the product occurs at pH 5-8, resulting in the direct acquisition of the product in crystalline form and high yield. This patent highlights his innovative approach to pharmaceutical synthesis.
Career Highlights
Ralph Hanni is associated with Mepha AG, a company known for its commitment to developing high-quality pharmaceutical products. His work at Mepha AG has allowed him to apply his inventive skills in a practical setting, contributing to the company's reputation for excellence in the pharmaceutical industry.
Collaborations
Throughout his career, Ralph Hanni has collaborated with talented individuals such as Iliya Vassilev Ognyanov and Angel Nikolov Konakchiev. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Ralph Hanni's contributions to pharmaceutical chemistry, particularly through his patent for dihydroartemisinin hemisuccinate, demonstrate his commitment to advancing medical science. His work at Mepha AG and collaborations with other professionals further highlight his role as a significant innovator in the field.